HILAX | VIHAX | HILAX / VIHAX | |
Total Expense Ratio | 1.18 | 0.17 | 694% |
Annual Report Gross Expense Ratio | 1.18 | 0.17 | 694% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | 20.694 | 16.179 | 128% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.29B | 10.2B | 81% |
Annual Yield % from dividends | 2.73 | 4.32 | 63% |
Returns for 1 year | 16.32 | 12.03 | 136% |
Returns for 3 years | 49.51 | 26.42 | 187% |
Returns for 5 years | 128.60 | 75.10 | 171% |
Returns for 10 years | 63.43 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VLLIX | 40.23 | 0.11 | +0.27% |
Value Line Larger Companies Focus Instl | |||
FGRCX | 25.39 | N/A | N/A |
Fidelity Advisor Mega Cap Stock C | |||
ETAHX | 30.29 | N/A | N/A |
Eventide Healthcare & Life Sciences A | |||
VSEMX | 220.76 | N/A | N/A |
Vanguard Extended Market Index Instl Sel | |||
BAFYX | 9.77 | N/A | N/A |
Brown Advisory Sustainable Sml-Cp Cr Ins |